期刊文献+

Adherence to treatment guidelines in the pharmacological management of chronic heart failure in an Australian population 被引量:2

Adherence to treatment guidelines in the pharmacological management of chronic heart failure in an Australian population
下载PDF
导出
摘要 Background To document the pharmacotherapy of chronic heart failure (CHF) and to evaluate the adherence to treatment guidelines in Australian population. Methods The pharmacological management of 677 patients (female 46.7%, 75.5 ±11.6 years) with CHF was retrospectively analyzed. Results The use of angiotensin converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARB) and β-blockers were 58.2 % and 34.7 %, respectively. Major reasons for non-use of ACE inhibitors/ARBs were hyperkalemia and elevated serum creatinine level. For patients who did not receive β-blockers, asthma and chronic obstructive pulmonary disease were the main contraindications. Treatment at or above target dosages for ACE inhibitors/ARBs and β-blockers was low for each medication (40.3% and 28.9%, respectively). Conclusions Evidenced-based medical therapies for heart failure were under used in a rural patient population. Further studies are required to develop processes to improve the optimal use of heart failure medications.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2011年第2期88-92,共5页 老年心脏病学杂志(英文版)
关键词 heart failure ACE inhibitors angiotensin receptor Β-BLOCKERS PROGNOSIS 慢性阻塞性肺疾病 药物治疗 澳大利亚 衰竭 心脏 管理 药理 人口
  • 相关文献

同被引文献13

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部